Unlocking the Blood-Brain Barrier for Enhanced Curcumin Delivery Using PEGylated Mesoporous Silica Nanoparticles

Author:

Sofi Balsam F.1,Darwesh Reem1,Elbialy Nihal S.1

Affiliation:

1. Medical Physics Program, Physics Department, Faculty of Sciences, King Abdulaziz University, Jeddah, 21589, KSA

Abstract

The blood-brain barrier is a physiological barrier that regulates the entry of substances the brain. BBB poses a challenge for delivering drugs to brain. To address this challenge, a nano-system (P/CurMSNs) was fabricated. The study evaluated P/CurMSNs potential to cross blood brain barrier, via various administration routes; intraperitoneal, intranasal, and intravenous using mice model. The intranasal administration of P/CurMSNs exhibited the most efficient curcumin delivery to the brain in 30 min, achieving 366 ±37 ng/ml relative to 264 ±22 ng/ml and 303± 41 ng/ml for intraperitoneal and intravenous routes, respectively. Post intranasal administration, drug pharmacokinetic parameters were significantly higher in brain and lower in plasma and vital organs, when compared to the other administration routes. In conclusion, P/MSNs emerged as a promising strategy for delivering drug across blood brain barrier via the three routes, particularly intranasal administration, offering a potential therapeutic approach for brain disorders with enhanced brain tissue targeting.

Publisher

American Scientific Publishers

Reference38 articles.

1. Neuroprotection by curcumin: A review on brain delivery strategies;Askarizadeh;International Journal of Pharmaceutics,2020

2. Nanoemulsion containing a synergistic combination of curcumin and quercetin for nose-to-brain delivery: In vitro and in vivo studies;Mahajan;Asian Pacific Journal of Tropical Biomedicine,2021

3. Curcumin-based nanomedicines in the treatment of inflammatory and immunomodulated diseases: An evidence-based comprehensive review;Laurindo;Pharmaceutics,2023

4. Solid lipid nanoparticles entrapping hydrophilic/amphiphilic drug and a process for preparing the same;Kaur;PCT Application Number: PCT/IN2012/000154 Dated,2012

5. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route;Patel;Journal of Drug Targeting,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3